CRISPR Therapeutics
CRSP
#3212
Rank
NZ$6.31 B
Marketcap
$73.66
Share price
-3.09%
Change (1 day)
-40.75%
Change (1 year)

Earnings for CRISPR Therapeutics (CRSP)

Earnings in 2024 (TTM): -NZ$0.6 Billion

According to CRISPR Therapeutics's latest financial reports the company's current earnings are NZ$35 Million. a decrease over its 2023 earnings that were of -NZ$0.27 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CRISPR Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.64 Billion140.62%
2023 -NZ$0.27 Billion-76.83%
2022 -NZ$1.15 Billion-271.4%
2021 NZ$0.66 B-209.04%
2020 -NZ$0.62 Billion-617.12%
2019 NZ$0.11 B-140.93%
2018 -NZ$0.29 Billion146.86%
2017 -NZ$0.12 Billion193.19%
2016 -NZ$39.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.26 Billion-60.60%๐Ÿ‡บ๐Ÿ‡ธ USA